On May 31, 2019 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, reported that the company plans to participate in the following conferences in June (Press release, Iovance Biotherapeutics, MAY 31, 2019, View Source;p=RssLanding&cat=news&id=2400226 [SID1234536726]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Showcasing Greater Philadelphia’s Life Sciences & Innovation Assets at BIO 2019 in Philadelphia, June 3, 2019
Location: Comcast Technology Center
Date/Time: Monday, June 3, 2019, from 3:30 p.m. – 6:30 p.m. EDT
Jefferies 2019 Healthcare Conference in New York, June 4-7, 2019
Corporate overview
Location: Grand Hyatt New York
Date/Time: Wednesday, June 5, at 11:30 a.m. EDT
A live and archived webcast of the presentation will be available by visiting the Investors section of the Iovance Biotherapeutics website at View Source

Session: Best of ASCO (Free ASCO Whitepaper) Panel
Location: Grand Hyatt New York
Date/Time: Thursday, June 6, from 12:15 p.m. – 1:15 p.m. EDT
24th Congress of the European Hematology Association (EHA) (Free EHA Whitepaper) in Amsterdam, June 13-16, 2019
Poster: Iovance Peripheral Blood Lymphocytes (PBL): A Potential Cell Therapy Strategy For The Treatment Of Chronic Lymphocytic Leukemia
Authors: Lavakumar Karyampudi et al.
Session: Gene therapy, cellular immunotherapy and vaccination – Biology & Translational Research
Abstract Number: PF447
Location: RAI Amsterdam
Date/Time: Friday, June 14, from 5:30 p.m. – 7:00 p.m. CEST